Mineralys Therapeutics, Inc. (MLYS)

Healthcare · Biotechnology · NASDAQ

Mineralys Therapeutics, Inc. (MLYS) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.60B and a free-cash-flow yield of -7.2%.

Market cap	$2.60B
Trailing P/E	—
FCF yield	-7.2%
Revenue growth (YoY)	—
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live MLYS data on Nama Insights →